EDGAR Filing Documents for 0001387131-16-003959

Form 8-K - Current report:

SEC Accession No. 0001387131-16-003959

Filing Date

2016-01-26

Accepted

2016-01-26 17:21:42

Documents

Period of Report

2016-01-25

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	admp-8k_01252016.htm	8-K	55273
2	CERTIFICATE OF DESIGNATION OF PREFERENCES	ex3-1.htm	EX-3.1	95447
3	FORM OF WARRANT DATED JANUARY 26, 2016	ex4-1.htm	EX-4.1	106701
4	AMENDED AND RESTATED WARRANT	ex4-2.htm	EX-4.2	108919
5	PURCHASE AGREEMENT	ex10-1.htm	EX-10.1	181638
6	REGISTRATION RIGHTS AGREEMENT	ex10-2.htm	EX-10.2	125698
7	PRESS RELEASE	ex99-1.htm	EX-99.1	9140
	Complete submission text file	0001387131-16-003959.txt		684285

Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130

Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400

Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)